207 related articles for article (PubMed ID: 17869274)
1. Coreceptor CD8-driven modulation of T cell antigen receptor specificity.
van den Berg HA; Wooldridge L; Laugel B; Sewell AK
J Theor Biol; 2007 Nov; 249(2):395-408. PubMed ID: 17869274
[TBL] [Abstract][Full Text] [Related]
2. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.
Laugel B; van den Berg HA; Gostick E; Cole DK; Wooldridge L; Boulter J; Milicic A; Price DA; Sewell AK
J Biol Chem; 2007 Aug; 282(33):23799-810. PubMed ID: 17540778
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface.
Wooldridge L; Hutchinson SL; Choi EM; Lissina A; Jones E; Mirza F; Dunbar PR; Price DA; Cerundolo V; Sewell AK
J Immunol; 2003 Dec; 171(12):6650-60. PubMed ID: 14662868
[TBL] [Abstract][Full Text] [Related]
4. CD8 coreceptor-mediated focusing can reorder the agonist hierarchy of peptide ligands recognized via the T cell receptor.
Clement M; Knezevic L; Dockree T; McLaren JE; Ladell K; Miners KL; Llewellyn-Lacey S; Rubina A; Francis O; Cole DK; Sewell AK; Bridgeman JS; Price DA; van den Berg HA; Wooldridge L
Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34272276
[TBL] [Abstract][Full Text] [Related]
5. MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.
Wooldridge L; Clement M; Lissina A; Edwards ES; Ladell K; Ekeruche J; Hewitt RE; Laugel B; Gostick E; Cole DK; Debets R; Berrevoets C; Miles JJ; Burrows SR; Price DA; Sewell AK
J Immunol; 2010 Apr; 184(7):3357-66. PubMed ID: 20190139
[TBL] [Abstract][Full Text] [Related]
6. T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding.
Cole DK; Dunn SM; Sami M; Boulter JM; Jakobsen BK; Sewell AK
Mol Immunol; 2008 May; 45(9):2700-9. PubMed ID: 18243322
[TBL] [Abstract][Full Text] [Related]
7. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
Shen L; Potter TA; Kane KP
J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
[TBL] [Abstract][Full Text] [Related]
8. High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRs.
Knezevic L; Wachsmann TLA; Francis O; Dockree T; Bridgeman JS; Wouters A; de Wet B; Cole DK; Clement M; McLaren JE; Gostick E; Ladell K; Llewellyn-Lacey S; Price DA; van den Berg HA; Tabi Z; Sessions RB; Heemskerk MHM; Wooldridge L
J Biol Chem; 2023 Aug; 299(8):104981. PubMed ID: 37390984
[TBL] [Abstract][Full Text] [Related]
9. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
[TBL] [Abstract][Full Text] [Related]
10. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.
Purbhoo MA; Boulter JM; Price DA; Vuidepot AL; Hourigan CS; Dunbar PR; Olson K; Dawson SJ; Phillips RE; Jakobsen BK; Bell JI; Sewell AK
J Biol Chem; 2001 Aug; 276(35):32786-92. PubMed ID: 11438524
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.
Wooldridge L; Lissina A; Vernazza J; Gostick E; Laugel B; Hutchinson SL; Mirza F; Dunbar PR; Boulter JM; Glick M; Cerundolo V; van den Berg HA; Price DA; Sewell AK
Eur J Immunol; 2007 May; 37(5):1323-33. PubMed ID: 17429845
[TBL] [Abstract][Full Text] [Related]
12. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface.
Wooldridge L; van den Berg HA; Glick M; Gostick E; Laugel B; Hutchinson SL; Milicic A; Brenchley JM; Douek DC; Price DA; Sewell AK
J Biol Chem; 2005 Jul; 280(30):27491-501. PubMed ID: 15837791
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.
Clement M; Ladell K; Ekeruche-Makinde J; Miles JJ; Edwards ES; Dolton G; Williams T; Schauenburg AJ; Cole DK; Lauder SN; Gallimore AM; Godkin AJ; Burrows SR; Price DA; Sewell AK; Wooldridge L
J Immunol; 2011 Jul; 187(2):654-63. PubMed ID: 21677135
[TBL] [Abstract][Full Text] [Related]
14. Role of CD8 in aberrant function of cytotoxic T lymphocytes.
Kessler B; Hudrisier D; Cerottini JC; Luescher IF
J Exp Med; 1997 Dec; 186(12):2033-8. PubMed ID: 9396772
[TBL] [Abstract][Full Text] [Related]
15. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities.
Hutchinson SL; Wooldridge L; Tafuro S; Laugel B; Glick M; Boulter JM; Jakobsen BK; Price DA; Sewell AK
J Biol Chem; 2003 Jul; 278(27):24285-93. PubMed ID: 12697765
[TBL] [Abstract][Full Text] [Related]
16. Detection of low avidity CD8(+) T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers.
Melenhorst JJ; Scheinberg P; Chattopadhyay PK; Lissina A; Gostick E; Cole DK; Wooldridge L; van den Berg HA; Bornstein E; Hensel NF; Douek DC; Roederer M; Sewell AK; Barrett AJ; Price DA
J Immunol Methods; 2008 Sep; 338(1-2):31-9. PubMed ID: 18675271
[TBL] [Abstract][Full Text] [Related]
17. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.
Buslepp J; Kerry SE; Loftus D; Frelinger JA; Appella E; Collins EJ
J Immunol; 2003 Jan; 170(1):373-83. PubMed ID: 12496422
[TBL] [Abstract][Full Text] [Related]
18. Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering.
Viola A; Salio M; Tuosto L; Linkert S; Acuto O; Lanzavecchia A
J Exp Med; 1997 Nov; 186(10):1775-9. PubMed ID: 9362538
[TBL] [Abstract][Full Text] [Related]
19. CD8
Dockree T; Holland CJ; Clement M; Ladell K; McLaren JE; van den Berg HA; Gostick E; L Miners K; Llewellyn-Lacey S; Bridgeman JS; Man S; Bailey M; Burrows SR; Price DA; Wooldridge L
Immunol Cell Biol; 2017 Jan; 95(1):68-76. PubMed ID: 27670790
[TBL] [Abstract][Full Text] [Related]
20. Partial agonism and independent modulation of T cell receptor and CD8 in hapten-specific cytotoxic T cells.
Preckel T; Breloer M; Kohler H; von Bonin A; Weltzien HU
Eur J Immunol; 1998 Nov; 28(11):3706-18. PubMed ID: 9842913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
